Finance & risk
Investment Memo One-Pager
Make the case for a deal before the partner meeting. Investors use it to argue for a check.
Make one freeFree, no account needed
What’s on It
- The one thing to act onRecommendation
- Short summaryThesis
- Key factsDeal Terms
- Numbered stepsWhat We Diligence Next
Sample One-Pager. Company and figures are made up.
Investment Memo: Halden Bio
Series A · $14M at $70M pre · Prepared for the partnership
Recommendation
Lead the round at $14M on a $70M pre-money, for 18% post. The decision in front of the partnership is whether assay turnaround is a real switching reason. We think the pilot data says it is.
Thesis
Assay turnaround is the bottleneck in early discovery, and Halden cuts it from eleven days to under two.
The wedge is narrow enough to win outright and adjacent to a much larger screening market.
Deal Terms
Pre-money$70M
Round size$14M
Our cheque$12.6M
Ownership post18%
Option pool12% post
Board1 of 5
What We Diligence Next
01
Assay reproducibility
Independent replication at two labs before we sign.
02
Pipeline quality
Reference every one of the six named pilot customers.
03
IP position
Freedom-to-operate opinion on the core claim.
Make One from Your File
Drop in a PDF, Word or PowerPoint file. Get your One-Pager in a minute or two.
Make one free